Salidroside Pre-Treatment Inhibits Hypertensive Renal Injury and Fibrosis Through Inhibiting Wnt/β-Catenin Pathway
Our experimental data demonstrate that SAL pre-treatment protects against Ang II-induced hypertensive renal injury and fibrosis by suppressing the Wnt/β-catenin pathway in vivo and in vitro.
Authors
- Jie Zhu (ORCID: https://orcid.org/0000-0003-4910-2828)
- Z. Zhang (ORCID: https://orcid.org/0000-0002-6230-235X)
- Yuting Luan (ORCID: https://orcid.org/0009-0003-9084-5129)
- Zhenyu Xu (ORCID: https://orcid.org/0000-0003-0942-5139)
- Liang Li (ORCID: https://orcid.org/0000-0001-9139-5025)
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-5246-5497)
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Seventh People's Hospital of Shanghai (CN)
Publication Details
- Journal
- Dose-Response
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1177/15593258241298045
- Primary Topic
- Medicinal Plants and Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00